or Try an Advanced Search...

    Technical Analysis for ACRV - Acrivon Therapeutics, Inc.

    Grade Last Price % Change Price Change
    B 8.86 5.85% 0.49
    ACRV closed up 5.85 percent on Friday, July 26, 2024, on 52 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ACRV trend table...
    Date Alert Name Type % Chg
    Expansion Breakout Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Up 5 Days in a Row Strength 0.00%
    Wide Bands Range Expansion 5.85%
    Overbought Stochastic Strength 5.85%
    Up 3 Days in a Row Strength 5.85%
    Up 4 Days in a Row Strength 5.85%
    Older End-of-Day Signals for ACRV ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Upper Bollinger Band about 5 hours ago
    Up 5% about 5 hours ago
    Upper Bollinger Band Resistance about 5 hours ago
    Up 3% about 8 hours ago
    60 Minute Opening Range Breakout about 8 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ACRV Chart by TradingView
    Basic chart:

    Profile

    Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops precision oncology medicines. The company's lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1/2 for use in the treatment of platinum-resistant ovarian cancer; endometrial and bladder cancer; and SCCs, including SCCHN, cervical, and anal cancer. It is also developing two preclinical drug programs used to predict tumor sensitivity based on custom OncoSignature tests. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Cancer Oncology Tumor Ovarian Cancer Bladder Cancer Gynaecological Cancer Anal Cancer

    Is ACRV a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 21 Is Acrivon Therapeutics, Inc. (ACRV) Stock Outpacing Its Medical Peers This Year?
    Jun 13 Acrivon Therapeutics: Can You Win In Clinical Trials With Selection Bias?
    Jun 5 Is Acrivon Therapeutics, Inc. (ACRV) Outperforming Other Medical Stocks This Year?
    May 29 Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference
    May 28 Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock
    May 24 5 Small Drug Stocks to Buy From a Recovering Industry
    May 20 Has Acrivon Therapeutics, Inc. (ACRV) Outpaced Other Medical Stocks This Year?
    May 14 Acrivon Therapeutics GAAP EPS of -$0.73 beats by $0.11
    May 14 Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
    May 10 Is a Surprise Coming for Acrivon Therapeutics (ACRV) This Earnings Season?
    See more ACRV news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.85
    52 Week Low 3.19
    Average Volume 105,263
    200-Day Moving Average 6.08
    50-Day Moving Average 7.38
    20-Day Moving Average 7.30
    10-Day Moving Average 7.84
    Average True Range 0.50
    RSI (14) 69.51
    ADX 30.66
    +DI 35.18
    -DI 10.67
    Chandelier Exit (Long, 3 ATRs) 7.38
    Chandelier Exit (Short, 3 ATRs) 7.00
    Upper Bollinger Bands 8.89
    Lower Bollinger Band 5.72
    Percent B (%b) 0.99
    BandWidth 43.44
    MACD Line 0.32
    MACD Signal Line 0.15
    MACD Histogram 0.1746
    Fundamentals Value
    Market Cap 196.64 Million
    Num Shares 22.2 Million
    EPS -2.26
    Price-to-Earnings (P/E) Ratio -3.92
    Price-to-Sales 0.00
    Price-to-Book 0.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.86
    Resistance 3 (R3) 9.75 9.31 9.69
    Resistance 2 (R2) 9.31 9.06 9.37 9.64
    Resistance 1 (R1) 9.09 8.90 9.20 9.19 9.58
    Pivot Point 8.65 8.65 8.71 8.70 8.65
    Support 1 (S1) 8.42 8.39 8.54 8.53 8.14
    Support 2 (S2) 7.98 8.24 8.04 8.08
    Support 3 (S3) 7.76 7.98 8.03
    Support 4 (S4) 7.86